Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy

Figure 3

(a) The univariate COX regression analysis based on the OS of RCC patients. (b) Survival analysis between low- and high-expression of ALOX5 groups. (c) The survival analysis between low- and high-expression of CCND1 groups. (d) The survival analysis between low- and high-expression of NR3C2 groups. (e) The survival analysis between low- and high-expression of PTGER3 groups. (f) The survival analysis between low- and high-risk groups. (g) The clinical-related ROC curve demonstrated the predictive value of clinical characteristics and risk score. (h) The time-dependent ROC curve demonstrated the predictive value of prognostic prediction model.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)